Allarity Therapeutics expands in-house lab to add proteomics and cell line research

Allarity Therapeutics expanded its in-house medical laboratory to include proteomics and cell line research to support stenoparib development.Key Highlights:Original SEC Filing: Allarity Therapeutics, Inc. [ ALLR ] - 8-K - Sep. 29, 2026This is an AI-powered summary. It may contain inaccuracies. Con…